SGHTSight Sciences, Inc.

$224M

Q2 2025 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$20M-8.5% YoY

Gross Profit

$17M84.8% margin

Operating Income

-$12M-59.6% margin

Net Income

-$12M-61.0% margin

EPS (Diluted)

$-0.23

QoQ Revenue Growth

+11.7%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$122M

Total Liabilities

$52M

Stockholders' Equity

$70M

Cash & Equivalents

$102M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$20M	$21M	-8.5%
Gross Profit	$17M	$18M	-9.6%
Operating Income	-$12M	-$13M	+7.8%
Net Income	-$12M	-$12M	+3.1%

Revenue Segments

Surgical Glaucoma

$19M98%

Dry Eye

$333,0002%

SGHT Q2 2025 Earnings — Sight Sciences, Inc. Revenue & Financial Results | Market Cap Arena